Summary
A combined pharmacodynamic and pharmacokinetic approach was made to study the pharmacodynamic half-life (Pd1/2) of amitriptyline (AT). Six depressed patients were treated with 150 mg of amitriptyline as a single oral dose at night for six or more weeks. Decreased tyramine sensitivity (DTS), an index of this drug's pharmacological activity, was determined serially at various intervals after the last dose. Plasma concentrations of AT and nortriptyline (NT) were also estimated at above intervals. It was possible to detect DTS for 228–300 h after the last oral dose and the mean Pd1/2 of this decline of pharmacodynamic effect was observed to be 135 h. However, no measurable amount of AT or NT was present after 84 h and the mean elimination plasma half-life (t1/2) of AT and NT were 37.7 and 38.9 h, respectively. (In this study, pharmacokinetic parameters of NT were directly related with those of AT.) Prolonged pharmacodynamic effect of this drug after discontinuation should be borne in mind in order to avoid drug interactions and autonomic complications, especially after overdosage. Pd1/2, as assessed by DTS, correlated directly with the t1/2 (r=0.91) and inversely with the plasma clearance rate (r=0.60) of NT. DTS test can be used as an alternative technique to assess the biological activity of a drug which inhibits noradrenaline reuptake mechanism and/or blocks α-adrenoceptors at the peripheral neuronal sites, especially, where facilities to measure plasma concentrations of such drugs are limited.
Similar content being viewed by others
References
Alexanderson B (1972) Pharmacokinetics of desmethylimipramine and nortriptyline in man after single and multiple oral doses. A crossover study. Eur J Clin Pharmacol 4:196–200
Braithwaite RA, Widdop B (1971) A specific gas chromatographic method for the measurement of steady-state plasma levels of amitriptyline and nortriptyline in patients. Clin Chem Acta 35:361–472
Gram LF, Anderson PB, Overo KF, Christiansen J (1976) Comparison of single dose kinetics of imipramine, nortriptyline and antipyrine in man. Psychopharmacology 50:21–27
Jørgensen A, Staehr P (1976) On the biological half-life of amitriptyline. J Pharm Pharmacol 28:62–64
Coppen A, Ghose K, Montgomery S, Rao R, Bailey J, Christiansen J, Mikkleson PL, Van Praag HM, Van de Poel F, Minsker EJ, Kozulja VG, Matussek N, Kungkunz G, Jørgensen A (1978) Amitriptyline plasma concentration and clinical effect: A WHO Collaboration Study. Lancet 1:63–66
Ariëns EJ (1974) Drug levels in the target tissue and effect. Clin Pharmacol Ther 16:155–175
Azarnoff DL (1974) Application of blood level data to clinical trials. Clin Pharmacol Ther 16:183–188
Gibaldi M, Nagashima R, Levy G (1969) Relationship between drug concentration in plasma or serum and amount of drug in body. J Pharmacol Sci 58:193–197
Ghose K, Coppen A, Turner P (1976) Autonomic actions and interactions of mianserin hydrochloride (Org. CB 94) and amitriptyline in patients with depressive illness. Psychopharmacology 49:201–204
Glassman AH, Bigger Jr. JT, Siardina EV, Kanton SJ, Perel JM, David M (1979) Clinical characteristics of imipramine induced orthostatic hypotension. Lancet 1:468–472
Coull DC, Crooks J, Dingwall-Fordyce I, Scott AM, Weir RO (1970) A method of monitoring drugs for adverse reactions. II. Amitriptyline and cardiac disease. Eur J Clin Pharmacol 3:51–55
Ghose K, Gupta R, Coppen A, Lund J (1977) Antidepressant evaluation and the pharmacological actions of FG 4963 in depressive patients. Eur J Pharmacol 42:31–37
Iversen LL (1965) Inhibition of noradrenaline uptake by drugs. J Pharm Pharmacol 17:62–64
Report to the Medical Research Council Psychiatry Committee (1965) Clinical trial of the treatment of depressive illness. Br Med J 1:881
Hamilton MJ (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Ghose K, Gifford LA, Turner P, Leighton M (1976) Studies of the interaction of desmethylimipramine with tyramine in man after a single oral dose and its correlation with plasma concentration. Br J Clin Pharmacol 3:334–337
Jørgensen A (1975) A gas liquid chromatographic method for the determination of amitriptyline and nortriptyline in human serum. Acta Pharmacol Toxicol 36:79–90
Torrell T (1937) Kinetics of distribution of substances administered to the body. II. The intravascular modes of administration. Arch Int Pharmacodyn 57:226–240
Greenblatt DJ, Kochweser J (1975) Drug Therapy: Clinical Pharmacokinetics. N Engl J Med 293:702–705
Wagner JG, Northam JI, Alway CD, Carpenter OS (1965) Blood levels of drug at equilibrium state after multiple dosing. Nature (Lond) 207:1301–1302
Carruthers SG, Hosler JP, Pentikairen P, Azarnoff DL (1978) Pamatol: Phase I evaluation of the pharmacodynamics of a cardioselective beta-adrenoceptor blocking drug. Clin Pharmacol Ther 24:168–174
Ghose K, Coppen A (1977) Noradrenaline, depressive illness and the action of amitriptyline. Psychopharmacology 54:57–60
Ghose K, Rao VAR, Coppen A, Bailey J (1978) Antidepressant activity and pharmacological interactions of ciclazindol. Psychopharmacology 57:109–114
Freyschuss U, Sjöqvist F, Tuck D (1970) Tyramine pressor effects in man before and during treatment with nortriptyline or ECT. Correlation between plasma level and effect of nortriptyline. Pharmacol Clin 2:72–78
Llisberg P, Mose H, Amidsen H, Jørgensen A, Hopfner Petersen HE (1978) A clinical trial comparing sustained release amitriptyline and conventional amitriptyline tablets in endogenously depressed patients with simultaneous determination of serum levels of amitriptyline and nortriptyline. Acta Psychiat Scand 57:426–435
Jørgensen A (1979) Personal communication
Gibaldi M, Levy G, Weintraub H (1971) Drug distribution and pharmacologic effects. Clin Pharmacol Ther 12:734–742
Gibaldi M, Levy G (1972) Dose-dependent decline of pharmacological effects of drugs with linear pharmacokinetic characteristics. J Pharm Sci 61:567–569
Borga O, Lunde KM (1970) Protein binding of nortriptyline and diphenylhydantoin in man. Acta Pharmacol Toxicol (Suppl) 28:16–17
Hansen C, Dunn WJ (1972) Linear relationship between lipophilic character and biological activity of drugs. J Pharm Sci 61:1–8
Ghose K (1980) Assessment of peripheral adrenergic activity and its interactions with drugs in man. Eur J Clin Pharmacol 17:233–238
Ghose K (1976) Correlation of pupil reactivity to tyramine or hydroxyamphetamine and tyramine pressor response in patients treated with amitriptyline or mianserin. Br J Clin Pharmacol 3:666–667
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ghose, K. Decreased tyramine sensitivity after discontinuation of amitriptyline therapy. Eur J Clin Pharmacol 18, 151–157 (1980). https://doi.org/10.1007/BF00561583
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00561583